Phase II for Human Genome Research

Human Genetic Diversity Enters the Commercial Mainstream

With computer-assisted DNA sequencing machines running faster and more cheaply, researchers are now entering Phase II of human genome research. Companies are patenting and privatizing the commercially-important bits of variation found in individuals, indigenous peoples, disease and disability groups, and ethnically-distinct communities.

PDF icon Download File0 bytes

Please consider supporting ETC's unique research and advocacy with a tax-deductible donation. Donate here